MedPath

Exploring potential drugs for amyotrophic lateral sclerosis in Chinese medicine based on data mining and Mendelian randomisation

Not Applicable
Conditions
Amyotrophic lateral sclerosis
Registration Number
ChiCTR2400088835
Lead Sponsor
Shaanxi Provincial Traditional Chinese Medicine Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

? Patients who meet the diagnostic standards of Western medicine and are diagnosed with ALS; <br>? Aged 30-85 years old; <br>? Complete clinical data, especially complete biochemical examination data before and after taking traditional Chinese medicine.

Exclusion Criteria

?Cases where the diagnosis and outcome are unclear, information is missing or safety is in doubt; <br>?Those with incomplete medication information and clinical data; <br>?Patients with comorbidities such as hypertension, diabetes, and other diseases that may affect kidney function;<br>?Patients with a combination of acute and chronic liver and kidney function abnormalities, malignant tumours and other diseases.<br>

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum creatinine;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath